{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:42:30Z","timestamp":1791348150234,"version":"4.3.1"},"reference-count":102,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1517\/13543776.2013.798648","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T06:08:43Z","timestamp":1368598123000},"page":"737-749","source":"Crossref","is-referenced-by-count":248,"title":["Anticancer carbonic anhydrase inhibitors: a patent review (2008 \u2013 2013)"],"prefix":"10.1517","volume":"23","author":[{"given":"Simona Maria","family":"Monti","sequence":"first","affiliation":[{"name":"Istituto di Biostrutture e Bioimmagini-CNR","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T","family":"Supuran","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Firenze, Laboratorio di Chimica Bioinorganica","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Simone","sequence":"additional","affiliation":[{"name":"Istituto di Biostrutture e Bioimmagini-CNR","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,5,15]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr200176r"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4324\/9780203475300","volume-title":"Carbonic anhydrase: its inhibitors and activators","author":"Supuran C","year":"2004","unstructured":"Supuran C. Carbonic anhydrases: catalytic and inhibition mechanisms, distribution and physiological roles. In: Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase: its inhibitors and activators. CRC Press, Boca Raton, FL; 2004. p. 1-23"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2467"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986710790979999"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1201\/9780203475300.ch9","volume-title":"Carbonic anhydrase: its inhibitors and activators","author":"Pastorekov\u00e1 S","year":"2004","unstructured":"Pastorekov\u00e1 S, Pastorek J. Cancer-related carbonic anhydrase isoenzymes and their inhibition. In: Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase: its inhibitors and activators. CRC Press, Boca Raton, FL; 2004. p. 255-81"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64038-2"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161208783877893"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161210793429841"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2009.07.027"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.03.015"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986712799034851"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1996.0223"},{"key":"e_1_3_1_15_1","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment","volume":"9","author":"Pastorek J","year":"1994","unstructured":"Pastorek J, Pastorekov\u00e1 S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-88","journal-title":"Oncogene"},{"key":"e_1_3_1_16_1","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff CC","year":"2000","unstructured":"Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000;60:7075-83","journal-title":"Cancer Res"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.3.2.618"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/9780470508169.ch8","volume-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Hoboken","author":"Pastorekova S","year":"2009","unstructured":"Pastorekova S, Barathova M, Kopacek J, Pastorek J. Carbonic anhydrase inhibitors targeting cancer: therapeutic, immunologic, and diagnostic tools targeting isoforms IX and XII. In: Supuran CT, Winum JY, editors. Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Hoboken. Wiley, New Jersey; 2009. p. 193-222"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-007-9064-0"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(99)01615-9"},{"key":"e_1_3_1_21_1","first-page":"1284","article-title":"Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism","volume":"8","author":"Helmlinger G","year":"2002","unstructured":"Helmlinger G, Sckell A, Dellian M, et al. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res 2002;8:1284-91","journal-title":"Clin Cancer Res"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21187"},{"key":"e_1_3_1_23_1","first-page":"1901","article-title":"Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells","volume":"58","author":"Lee AH","year":"1998","unstructured":"Lee AH, Tannock IF. Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. Cancer Res 1998;58:1901-8","journal-title":"Cancer Res"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00994.x"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1042\/bse0430165"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4827(03)00351-3"},{"key":"e_1_3_1_27_1","first-page":"977","article-title":"Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment","volume":"13","author":"Zavadova Z","year":"2005","unstructured":"Zavadova Z, Zavada J. Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment. Oncol Rep 2005;13:977-82","journal-title":"Oncol Rep"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1111"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.08.088"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0908301106"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2520"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.09.011"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2009.10.060"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/pr300565w"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M800938200"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7608"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.21.12596"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02523.x"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-005-0068-2"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2470"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-065"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64048-5"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2010.03.004"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004180000181"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64762-1"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i17.2616"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25491"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/6.1.68"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/002215540004801203"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.4.257"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603530"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161301298"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161208783877910"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.10.043"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0501073"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.14.5.667"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.05.009"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.10025"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2003.12.029"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.09.002"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2012.698264"},{"key":"e_1_3_1_62_1","unstructured":"Nicox SA Supuran CT Benedini F et al. Nitrate esters of carbonic anhydrase inhibitors. WO071421; 2008"},{"key":"e_1_3_1_63_1","unstructured":"Stichting Maastricht Radiation Oncology Maastro Clinic. Dubois LJ Lambin P et al. Cancer targeting using carbonic anhydrase isoform IX inhibitors. WO087115; 2012"},{"key":"e_1_3_1_64_1","unstructured":"Molecular Insight Pharm Inc. Zimmerman C Babich JW et al. Inhibitors of carbonic anhydrase IX. WO089383; 2009"},{"key":"e_1_3_1_65_1","unstructured":"Univ Firenze Uni Oslo Univ Manchester. et al. Carbonic anhydrase inhibitors. WO098610; 2011"},{"key":"e_1_3_1_66_1","unstructured":"Univ Notre Dame de la Paix. Masereel B Frederick R Supuran CT. Tetraline sulfonamide derivatives for use in the treatment of proliferative disorders. WO175654; 2012"},{"key":"e_1_3_1_67_1","unstructured":"Auspex Pharmaceuticals Inc. Sulfonamide inhibitors of Carbonic anhydrase. US2010317655; 2010"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm031079w"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm990479"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756360009040695"},{"key":"e_1_3_1_71_1","unstructured":"Institute of Virology of the Slovak Academy of Sciences. CA IX-specific inhibitors. US095707; 2008"},{"key":"e_1_3_1_72_1","unstructured":"Scozzafava A; Institute of Virology Supuran CT. CA IX-specific inhibitors. AU211499; 2012"},{"key":"e_1_3_1_73_1","unstructured":"Institute of Virology. Supuran C Scozzafava A. CA IX-specific inhibitors. AU200368; 2010"},{"key":"e_1_3_1_74_1","unstructured":"Institute of Virology of the Slovak Academy of Sciences. CA IX-specific inhibitors. US220001; 2008"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.04.018"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.06.019"},{"key":"e_1_3_1_77_1","unstructured":"Union Life Sciences Ltd. Sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents. US138291; 2008"},{"key":"e_1_3_1_78_1","unstructured":"Supuran CT Scozzafava A. Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents. WO 137092; 2006"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1039\/c0cc02707c"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm101541x"},{"key":"e_1_3_1_81_1","unstructured":"MetaSignal Therapeutics Inc. Supuran C Dedhar S et al. Novel sulfonamide compounds for inhibition of metastatic tumor growth. WO021963; 2012"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja809683v"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm901287j"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.10.094"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4261"},{"key":"e_1_3_1_86_1","unstructured":"MetaSignal Therapeutics Inc. Supuran C Dedhar S et al. Carbonic anhydrase inhibitors with antimetastatic activity. WO070024; 2012"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0223-5234(98)80017-2"},{"key":"e_1_3_1_88_1","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","author":"Lock FE","year":"2012","unstructured":"Lock FE, McDonald PC, Lou Y, et al. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene 2012; doi: 10.1038\/onc.2012.550","journal-title":"Oncogene"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087057108315739"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.06.040"},{"key":"e_1_3_1_91_1","unstructured":"Univ Tampere. Supuran CT Parkkila S. Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms. WO139678; 2010"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.06.002"},{"key":"e_1_3_1_93_1","unstructured":"Univ Brown. Composition and methods for loop diuretics with consistent bioavailability. US0053156; 2012"},{"key":"e_1_3_1_94_1","unstructured":"Feldman DL Webb RL. Pharmaceutical composition comprising a renin inhibitor calcium channel blocker and a diuretic. US0071470; 2012"},{"key":"e_1_3_1_95_1","unstructured":"Neurotherapeutics Pharma Inc. Diuretic and diuretic-like compound analogs. US234721; 2012"},{"key":"e_1_3_1_96_1","unstructured":"Sanofi Aventis. Combination of dronedarone with at least one diuretic and therapeutic use thereof. US0136899; 2011"},{"key":"e_1_3_1_97_1","unstructured":"Woo SH. Controlling body fluid condition using diuretics. WO029899; 2009"},{"key":"e_1_3_1_98_1","unstructured":"Bayer Schering Pharma Ag. Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-II antagonist and\/or a diuretic. MX005023; 2011"},{"key":"e_1_3_1_99_1","unstructured":"Sciele Pharma Inc. Dillaha L Schutter E. Alpha-2-Adrenergic agonists and angiotensin II receptor antagonist composition. WO065489; 2010"},{"key":"e_1_3_1_100_1","unstructured":"Pharmascience Inc. Talwar N Sebastian D Philip M. A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide. WO147026; 2011"},{"key":"e_1_3_1_101_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161208783877947"},{"key":"e_1_3_1_102_1","first-page":"6","article-title":"Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug","author":"Lee HS","year":"2012","unstructured":"Lee HS, Bae T, Lee JH, et al. Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug. BMC Syst Biol 2012;6-80","journal-title":"BMC Syst Biol"},{"key":"e_1_3_1_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2423(06)42005-9"},{"key":"e_1_3_1_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-0980-z"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543776.2013.798648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:23:22Z","timestamp":1770917002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543776.2013.798648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,15]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1517\/13543776.2013.798648"],"URL":"https:\/\/doi.org\/10.1517\/13543776.2013.798648","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,15]]}}}